This section is for searching all documents on our website.
We are currently updating documents and content to reflect the transition into an ICB. You may therefore notice some references to the CCG remain temporarily. Over time, these will be updated.
These terms of reference set out the membership, remit, authority, responsibilities and reporting arrangements of the Committee.
These terms of reference set out the membership, remit, responsibilities and reporting arrangements of the Committee and shall have effect as if incorporated into the CCG’s constitution.
These terms of reference set out the membership, remit, authority, responsibilities and reporting arrangements of the Committee.
These terms of reference set out the membership, the remit, responsibilities and reporting arrangements of the Committee.
These terms of reference set out the membership, the remit, responsibilities and reporting arrangements of the Committee and may only be changed with the approval of the Board.
These terms of reference set out the membership, remit, authority, responsibilities and reporting arrangements of the Committee.
The purpose of this policy is to provide a framework for the ICBs in their interaction with pharmaceutical companies and other device and appliance manufacturers of prescribable products..
CCG expenditure over £25,000 in August 2018.
CCG expenditure over £25,000 in July 2018.
This is an Exceptional Funding Request policy for homeopathy treatment.